This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Evangelou, A. Articles by Brown, T. J. Search for Related Content PubMed PubMed Citation Articles by Evangelou, A. Articles by Brown, T. J.

Androgen Modulation of Adhesion and Antiadhesion Molecules in PC-3 Prostate Cancer Cells Expressing Androgen Receptor

Cancer and Blood Research Program (A.E., M.L.), The Hospital for Sick Children, Toronto, Ontario, Canada M5G 1X8; Division of Reproductive Science (A.E., T.J.B.), The Samuel Lunenfeld Research Institute, Mt. Sinai Hospital, Toronto, Ontario, Canada M5G 1X5; The Banting and Best Department of Medical Research (A.M.), University of Toronto, Ontario, Canada M5G 1L6; Department of Zoology (A.E., T.J.B.), University of Toronto, Toronto, Ontario, Canada M5S 3G5; Department of Obstetrics and Gynecology (M.L., T.J.B.), University of Toronto, Toronto, Ontario, Canada M5G 1L4; and Department of Immunology (M.L.), University of Toronto, Toronto, Ontario, Canada M5S 1A8

Address all correspondence and requests for reprints to: Theodore J. Brown, Ph.D., Associate Professor, Department of Obstetrics and Gynecology, Samuel Lunenfeld Research Institute, 600 University Avenue, University of Toronto, Toronto, Canada M5G 1X5. E-mail: brown{at}mshri.on.ca.

The metastatic spread of cancer cells involves a complex process of detachment via antiadhesion molecules and attachment and migration through adhesion. In the prostate, androgens are generally thought to contribute to the development and progression of prostate cancer by promoting cell proliferation and survival through poorly defined mechanisms. We have reported previously that PC-3 prostate cancer cells, which are unresponsive to androgens, show androgen-dependent detachment and ultimately apoptosis when stably transfected with a full-length human androgen receptor (AR) cDNA. We now demonstrate that treatment of these cells with 5-dihydrotestosterone (DHT) for 24 or 48 h increased the expression of antiadhesion mucin MUC-1 at the cell surface as detected by flow cytometry with two independent antibodies. This increase in protein was concordant with up-regulation of MUC-1 mRNA in the AR-transfected PC-3 sublines, as determined by quantitative RT-PCR. Treatment with DHT for 48 h also down-regulated the cell surface expression of 2ß1-integrin but having little effect on the levels of 3ß1- and 5ß1-integrins. Androgen also decreased, in a dose-dependent manner, the adhesion of AR-transfected PC-3 cells to collagen type I, which was shown to be specifically inhibited by blocking antibody to 2ß1-integrin. The present data demonstrate that DHT can modulate expression of adhesion and antiadhesion molecules and suggest that this effect of androgen might contribute to prostate cancer progression.

This article has been cited by other articles:

				S. N. Sahu, S. Nunez, G. Bai, and A. Gupta Interaction of Pyk2 and PTP-PEST with leupaxin in prostate cancer cells Am J Physiol Cell Physiol, June 1, 2007; 292(6): C2288 - C2296. [Abstract] [Full Text] [PDF]

				M. D. Winthrop, S. J. DeNardo, H. Albrecht, G. R. Mirick, L. A. Kroger, K. R. Lamborn, C. Venclovas, M. E. Colvin, P. A. Burke, and G. L. DeNardo Selection and Characterization of Anti-MUC-1 scFvs Intended for Targeted Therapy Clin. Cancer Res., September 1, 2003; 9(10): 3845S - 3853. [Abstract] [Full Text] [PDF]

				E. Baldi, L. Bonaccorsi, and G. Forti Androgen Receptor: Good Guy or Bad Guy in Prostate Cancer Invasion? Endocrinology, May 1, 2003; 144(5): 1653 - 1655. [Full Text] [PDF]